BG Medicine Inc (OTC:BGMD) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Noubar Afeyan Other companies: Generate Biomedicines, Inc. (Chair of the Board · Since at least Feb 26, 2026); Foghorn Therapeutics Inc. (Director · Since at least Jan 13, 2026); Moderna, Inc. (Director · Since at least Dec 7, 2018); Omega Therapeutics Inc (Director · Jul 29, 2021 – Jun 7, 2023 · Past); Kaleido Biosciences, Inc. (Director · Feb 27, 2019 – Mar 4, 2019 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – May 12, 2022 · Past); Evelo Biosciences, Inc. (Director · May 8, 2018 – Jun 12, 2019 · Past); Cartesian Therapeutics, Inc. (Director · Jun 21, 2016 – Jun 21, 2016 · Past); Seres Therapeutics, Inc. (Director · Jun 25, 2015 – Jun 18, 2019 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – Mar 20, 2014 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Sep 25, 2013 · Past); Color Kinetics Inc (Director · Jan 3, 2006 – Aug 24, 2007 · Past); Agenus Inc. (Director · Jan 13, 2005 – Jun 7, 2007 · Past) | Director · Since at least Feb 3, 2011 |
| Michael Rogers Other companies: Akebia Therapeutics, Inc. (Director · Since at least Dec 12, 2018); Aravive Inc (Director · Sep 15, 2020 – Sep 23, 2022 · Past); Whitehawk Therapeutics, Inc. (See Remarks · Nov 15, 2017 – May 14, 2019 · Past); Keryx Biopharmaceuticals Inc (Director · Mar 31, 2016 – Dec 12, 2018 · Past); Acorda Therapeutics Inc (Chief Financial Officer · Oct 7, 2013 – May 11, 2016 · Past); Fortress Biotech, Inc. (Director · Sep 13, 2011 – Feb 7, 2013 · Past); EyePoint, Inc. (Director · Jul 13, 2007 – Jun 25, 2019 · Past); Indevus Pharmaceuticals Inc (Executive Vice President · Feb 17, 2006 – Feb 23, 2009 · Past) | EVP, CFO and Treasurer · Feb 3, 2010 – Feb 22, 2012 · Past |
| Brian S. Posner Other companies: Dyne Therapeutics, Inc. (Board Member · Since at least Oct 1, 2025); Arch Capital Group Ltd. (Director · Since at least Nov 4, 2010); Bioverativ Inc (Director · Jan 10, 2017 – Mar 8, 2018 · Past); Anadys Pharmaceuticals Inc (Director · Aug 22, 2011 – Aug 22, 2011 · Past); Biogen Inc. (Director · Jul 23, 2008 – Dec 31, 2022 · Past); LMP Capital and Income Fund Inc (Officer of the Adviser · Oct 11, 2006 – Oct 11, 2006 · Past) | Director · Since at least Feb 13, 2012 |
| Stelios Papadopoulos Other companies: Ovid Therapeutics Inc. (Director, Member of the Audit and Compensation Committees · Since at least Mar 1, 2025); Regulus Therapeutics Inc (Director · Since at least Oct 4, 2012); Exelixis, Inc. (Chair of the Board, Exelixis, Inc. · Since at least May 24, 2012); Eucrates Biomedical Acquisition Corp. (Director · Oct 23, 2020 – Nov 24, 2020 · Past); Biogen Inc. (Director · Jun 8, 2012 – Jun 15, 2022 · Past) | Director · Since at least Nov 9, 2011 |
| Stéphane Bancel Other companies: Generate Biomedicines, Inc. (Director · Since at least Feb 26, 2026); Moderna, Inc. (Chief Executive Officer, Moderna · Since at least Dec 7, 2018); Syros Pharmaceuticals, Inc. (Director · Jun 29, 2016 – Sep 15, 2016 · Past); Targanta Therapeutics Corp (Director · Aug 25, 2008 – Aug 25, 2008 · Past) | Executive Chairman of the Board · Since at least Feb 3, 2011 |
| Harry W Wilcox Other companies: T2 Biosystems, Inc. (Director · Aug 6, 2014 – Jun 17, 2016 · Past); EXACT Sciences Corporation (Senior Vice President and CFO · Feb 16, 2006 – Feb 16, 2006 · Past) | Director · May 12, 2015 – Nov 18, 2015 · Past |
| Timothy Harris Other companies: Bioverativ Inc (EVP, R & D · Apr 10, 2017 – Mar 8, 2018 · Past); CapForce Inc. (Director · May 4, 2015 – Jun 13, 2018 · Past) | Director · Since at least Feb 3, 2011 |
| Charles H Abdalian Jr Other companies: Coley Pharmaceutical Group Inc (SVP, Finance and CFO · Feb 16, 2007 – Jan 4, 2008 · Past) | EVP & Chief Financial Officer · Oct 18, 2012 – Dec 10, 2012 · Past |
| Harrison M Bains Jr Other companies: Tvardi Therapeutics, Inc. (Director · Jul 16, 2014 – Jun 1, 2023 · Past) | Director · Jun 12, 2013 – Jun 3, 2014 · Past |
| Jeffrey R Luber Other companies: EXACT Sciences Corporation (President and CEO, Director · Feb 16, 2006 – Mar 31, 2009 · Past) | Director · Feb 4, 2016 – Feb 4, 2016 · Past |
| Anastasia Rader | SVP, Executive Operations & HR · Apr 26, 2013 – Feb 4, 2014 · Past |
| Aram Adourian | Senior Vice President and Chief Scientific Officer · Since at least Nov 4, 2026 |
| Carol A. Adiletto | Vice President, Clinical and Regulatory Affairs · Since at least Nov 4, 2026 |
| Charles H. Abdalian | Executive Vice President and CFO · Since at least Nov 5, 2026 |
| Eric Bouvier | President, CEO, Director · Jan 9, 2012 – May 23, 2012 · Past |
| Harrison M. Bains | Director · Since at least Nov 5, 2026 |
| Howard Rosen | Vice President, Sales and Marketing · Since at least Nov 4, 2026 |
| Neal Gordon | SVP, Biomarker Discovery · Feb 3, 2011 – Feb 22, 2012 · Past |
| Paul R. Sohmer | Director, President and CEO · Since at least May 8, 2013 |
| Pieter van der Meer | Director · Feb 3, 2011 – Feb 9, 2011 · Past |
| Stacie Rader | Senior Vice President, Executive Operations & Human Resources · Since at least Nov 4, 2026 |
| Thomas B. Mortensen | Vice President, Sales - Europe · Since at least Nov 4, 2026 |
| William Densel | General Manager, CardioSCORE · Aug 8, 2012 – Aug 8, 2012 · Past |